Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Expands By 415.8%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 4,070 shares, a growth of 415.8% from the July 30th total of 789 shares. Based on an average daily volume of 711 shares, the short-interest ratio is presently 5.7 days.

bioAffinity Technologies Price Performance

BIAFW stock traded up $0.03 on Friday, reaching $0.11. The company had a trading volume of 30 shares, compared to its average volume of 2,369. bioAffinity Technologies has a 1 year low of $0.05 and a 1 year high of $0.81. The company’s fifty day moving average is $0.11 and its 200 day moving average is $0.21.

About bioAffinity Technologies

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.